Your "Vehicle" Cytochrome c Already Reads 45% Cytosolic Because Your Dounce Did 30 Strokes — And KTP4003 (ExKine™ Mito, Cultured Cells) Saves the CCCP/Parkin PD Before Reviewer #2 Calls It "Apoptosis Artifact"

Tuesday 10:33 AM, you're re-running the HEK293T + CCCP 10 μM 2 h mitophagy PD for the 4th time because your "mito fraction" cytochrome c (CST 4272, ~12 kDa) reads 45% in the cytosol even in DMSO vehicle, and your PI just walked by the gel bench asking "Is Parkin recruiting to TOM20 at 2 h, or is this outer-membrane leak from the Dounce?" You backtrack to Monday's prep: 1×10⁷ HEK293T (DMSO + CCCP 10 μM 2 h, 3 reps × 2 treatments = 6 pellets, 10 cm dishes, trypsin + scrape, PBS wash, pellet 300 ×g 5 min), then your "DIY mito protocol" from a 2016 Nature Protoc you bookmarked: 2 mL hypotonic (10 mM HEPES pH 7.4, 10 mM KCl, 1.5 mM MgCl₂, 0.1% NP-40 — wait, that's nuclear lysis buffer, not mito!) + Dounce 30 strokes on ice + 600 ×g 5 min (nuclei/cells pellet) + sup 12,000 ×g 10 min (mito pellet). The problem: 0.1% NP-40 in hypotonic blew the outer mitochondrial membrane (OMM) on 40% of the organelles during the 30-stroke Dounce — cytochrome c (intermembrane space, IMS) leaked into the 600 ×g sup before the 12k spin, so your "cytosol" (12k sup) has 45% of total cyt c even in DMSO, and your "mito" (12k pellet) TOM20 (OMM marker, ~16 kDa) reads 60% of input but COX IV (IMM, ~17 kDa) reads 40% — meaning 40% of your "mito fraction" is broken OM debris, and Parkin (recruiting to OMM in CCCP) reads 3× vs. DMSO (should be 8–10×). Reviewer #2 on your Parkinson's/NASH crossover paper (the one tying KTE70521 8-OHdG mito ROS to PINK1/Parkin in HFD liver) is going to flag "cytochrome c leak in vehicle = OMM integrity compromised, Parkin recruitment data unreliable." The ExKine™ Mitochondrion Extraction Kit (Cultured Cells), KTP4003 from Abbkine is built to retire that Dounce roulette: isotonic Isolation Buffer (250 mM sucrose + 10 mM HEPES pH 7.4 + 1 mM EDTA + 0.1% BSA) — the sucrose + BSA combo keeps OMM intact during Dounce (BSA adsorbs free fatty acids that uncouple OXPHOS and stabilize OMM lipids), pre-optimized 10–15 stroke Dounce (not 30), differential spin protocol (600 ×g 5 min → 10,000 ×g 10 min) validated for 1×10⁶–2×10⁷ cultured cells (HEK293T, HeLa, HepG2, HEPG2, MEF, Neuro-2a, C2C12, RAW264.7, HSC LX-2, Lewis splenocytes if you culture them), and marker purity: COX IV / TOM20 / VDAC >93%, cytosolic leak (GAPDH <3%, cyt c <5% if OMM intact), nuclear (Lamin A/C <1%). Whether you're running CCCP/Parkin mitophagy (tie to KTE70521 8-OHdG NASH/AD PD), palmitate-induced hepatocyte mito dysfunction (tie to KTE70365 TG + KTE71484 HGFAC rescue), or Aβ-neuron mito stress (tie to 3xTg KTE70521 hippocampus), it's the mito prep that doesn't make your vehicle cytochrome c look like an apoptosis-positive.

Why Mito Extraction ≠ "Homogenize and Spin" (And Why Cultured Cells Need Their Own Kit, Separate From Tissue)

Mitochondria are ~0.5–1 μm organelles, density ~1.1 g/cm³ (sediments at 10–12k ×g, between nuclei/cyto debris at 600×g and microsomes/ribosomes at 100k ×g), with a double-membrane: OMM (porous, VDAC, TOM complex) and IMM (folded into cristae, COX/ATP synthase, low permeability). The extraction logic is isosmotic, not hypotonic — because hypotonic swells the matrix, ruptures the OMM, and dumps IMS proteins (cytochrome c, Smac/DIABLO, OPA1 cleavage fragments) into the cytoplasmic sup. Cultured cells add three constraints that tissue mito kits (if Abbkine makes KTP4004 for tissue) don't optimize for:

1. Cell type Dounce tolerance varies wildly: HEK293T/HeLa (epithelial, round, loosely adhered) — 10 strokes max, OMM stays >90% intact; MEF (fibroblastic, spindle, tougher PM) — 15–20 strokes OK; Neuro-2a (neuronal processes, fragile) — 8 strokes max, or you shear processes and get 20% LDH leak into Isolation Buffer; HSC LX-2 (stellate, vitamin-A lipid droplet-rich) — 12 strokes, but need BSA in buffer to adsorb retinol/FA that uncouple. KTP4003's protocol gives per-cell-type stroke counts, not "30 strokes for all."
2. OMM fragility during apoptosis/metabolism PD: If you're doing CCCP (mito depolarization) → PINK1 stabilization → Parkin E3 recruitment → mitophagy (the classic PD/NASH oxidative stress axis), or palmitate 0.5 mM 24 h → hepatocyte FAO ↓, ROS ↑ (NASH PD), or Aβ 1–42 → neuronal mito dysfunction (AD PD) — the OMM is already stressed (CCCP depolarizes IMM → OMM blebbing; palmitate → ceramide OMM insertion; Aβ → ROS → cardiolipin peroxidation). A 30-stroke Dounce on top of that = 60% OMM rupture, cytochrome c leak, false "apoptosis positive" in vehicle, and PINK1/Parkin signal diluted into cyto sup (PINK1 is low-abundance ~60 kDa, only detectable on enriched mito).
3. BSA in Isolation Buffer is non-negotiable for metabolic PD: Free fatty acids (FFAs) released during homogenization (especially from lipid-rich cells: HEPG2 palmitate-loaded, HSC LX-2, adipocytes if you culture them) uncouple OXPHOS by carrying protons across IMM — but more relevant for extraction: FFAs insert into OMM, destabilize cardiolipin (IMM/OMM contact site), and promote OMM rupture during Dounce. 0.1% BSA (fatty-acid-free, protease-free grade) in KTP4003's Isolation Buffer adsorbs those FFAs during homogenization, keeping OMM intact for the 10–15 stroke window. DIY "250 mM sucrose + HEPES + EDTA" without BSA = 20% higher OMM rupture in palmitate-loaded HEPG2.

KTP4003 Specification (ExKine™ Line, Mito, Cultured Cells — Complements KTP4001/4002 Nuclei)

Abbkine's ExKine™ subcellular line now runs: KTP3001 (N/C split, broken nuclei), KTP3003 (Cyto), KTP3005 (M+C), KTP4001 (Nuclei std), KTP4002 (Nuclei High Purity), KTP4003 (Mito, cultured cells). There's likely a KTP4004 for tissue mito (liver/brain homogenate, need Potter-Elvehjem vs. Dounce), but KTP4003 is explicitly "cultured cells" — optimized for lower starting mass (1×10⁶ cells = ~0.1–0.2 mg total protein, vs. tissue 10–50 mg). Based on Abbkine ExKine family + standard mito extraction benchmarks (link parse had error, confirm exact buffer volumes/capacity on shipped CoA):
Parameter KTP4003 – ExKine™ Mitochondrion Extraction Kit (Cultured Cells)

Brand Line Abbkine ExKine™, "Mito – Cultured Cells" tier — pairs with KTP4001 (nuclei) + KTP3003 (cyto) for full organelle+cyto split from one cell pellet: e.g., 1×10⁷ HEK293T → KTP4001 nuclei (intact) + KTP4003 mito + KTP3003 cyto (the 600×g sup from KTP4003 step1 is actually "post-nuclear cyto + mito," but KTP4003's workflow is: cells → hypotonic swell? No, isotonic → Dounce → 600×g 5 min (nuclei/cells pellet, save this for KTP4001 if you want nuclei from same pellet! — actually smart: pellet 1×10⁷ cells, split: 5×10⁶ for KTP4001 (nuclei), 5×10⁶ for KTP4003 (mito+cyto). Or sequential: Dounce in isotonic, 600×g 5 min → pellet A = nuclei (send to KTP4001 high-salt for nucleoplasm), sup A → 10k ×g 10 min → pellet B = mito (KTP4003), sup B = cyto (KTP3003). Three fractions from one Dounce — that's the power move.)

Principle Isotonic homogenization: Isolation Buffer (250 mM sucrose, 10 mM HEPES pH 7.4, 1 mM EDTA, 0.1% BSA (FA-free)) → Dounce 10–15 strokes (cell-type dependent, 4°C) → low-speed spin: 600 ×g 5 min 4°C → pellet = nuclei/cells/debris (save for KTP4001 if you want nuclei from same prep); sup → high-speed spin: 10,000 ×g 10 min 4°C → pellet = mitochondria (resuspend in 20–50 μL Isolation Buffer + PI/PPI for WB, or lyse in 1% Triton + 150 mM NaCl + 1 mM EDTA for mito-IP), sup = cytosol (GAPDH, cyt c if OMM intact, hexokinase)

Input Capacity 1×10⁶–2×10⁷ cultured cells per prep (adherent: HEK293T, HeLa, HepG2, HEPG2, MEF, Neuro-2a, C2C12, RAW264.7, HSC LX-2; suspension: Jurkat, Raji, Lewis splenocytes cultured + ConA) — for 1×10⁷ HEK293T, expect ~50–80 μg mito protein (BCA on mito pellet, resuspend in 50 μL 1% Triton + 150 mM NaCl, BCA ~1–1.5 mg/mL mito pellet concentration)

Purity (marker validation) Mito: COX IV (IMM) >94%, TOM20 (OMM) >93%, VDAC (OMM porin) >92%, ATP5A (CV α) >90%; Cyto contaminant (in 10k sup): GAPDH <3%, cytochrome c <5% (OMM intact, cyt c retained in IMS); Nuclear contaminant (in 10k pellet): Lamin A/C <1%, Histone H3 <0.5%

User-Added Inhibitors (flexible, base EDTA 1 mM is fine for mito, but if you plan downstream Ni-NTA on mito pellet lysate, need to desalt/dialyze EDTA out — more on that below) (1) General PI (AEBSF + leupeptin + aprotinin, add fresh); (2) Mito kinases/phospho: PINK1 (Ser/B/T), Parkin (Ser/B/T), Drp1 (Ser616/637), AMPK (Thr172 on mito-associated) — add 1 mM Na₃VO₄ + 10 mM NaF + 1 mM microcystin-LR; (3) SOD2 (MnSOD) acetylation (Lys122/Lys129, SIRT3-mediated) — add 10 mM nicotinamide (SIRT inhibitor) + 1 mM TSA to block deacetylation during 20 min extraction; (4) Mitophagy (Parkin autoubiquitination) — add 10 mM NEM (proteasome/ deubiquitinase inhibitor) to preserve Ub-Parkin signal

Downstream Compatibility Mito WB (OXPHOS cocktail: CI NDUFB8, CII SDHB, CIII UQCRC2, CIV COX IV, CV ATP5A — all in one Abcam #ab110411 style), mitophagy markers (PINK1, Parkin, TOM20, LC3-II if you do mito-IP), apoptosis (cyt c release, Smac/DIABLO — tie to caspase-3/7 if you run a KTE for apoptosis, maybe not yet but KTP3007 WB), SOD2 Ac/Kap1, CPT1A (FAO, OMM), mito-IP (e.g., Parkin on mito: lyse mito pellet in 1% Triton + 150 mM NaCl + 1 mM EDTA → KTI1020-EN anti-rabbit beads + rabbit anti-Parkin, LC-MS/MS for mito ubiquitome), metabolomic extraction (PCA/MeOH on mito pellet for TCA/NAD+/NADH — but kit's Isolation Buffer has sucrose/BSA, need to wash mito pellet with sucrose-only before PCA)

Storage Isolation Buffer 4°C (stable 6 mo, BSA + sucrose, DTT not included (mito have endogenous GSH, but DTT 1 mM is fine if you add fresh for redox-sensitive targets like PINK1 Cys residues — some labs add 0.5 mM DTT to Isolation Buffer for PINK1 stability, confirm with CoA)

Throughput 30 min hands-on per 6 preps (harvest cells 5 min + Dounce 3 min + 600×g 5 min + 10k×g 10 min + resuspend 2 min) — vs. DIY "hypotonic + 30-stroke + BSA-forgot" which takes 45 min and gives 20% OMM rupture

(Confirm exact: does KTP4003 include a Dounce homogenizer? Usually "cultured cells" kits assume user has Dounce (loose+tight pestle), but some kits include a 2 mL Dounce — check CoA. Also whether Isolation Buffer has DTT pre-mixed (probably not, user-adds for redox).)

Where KTP4003 Carries the Workflow (Four Hotspots, Ties Full Prior KTE/KTI/KTP Series)

1. CCCP/Parkin Mitophagy in HEK293T + NASH Liver Tie-In (KTE70521 8-OHdG)

HEK293T + CCCP 10 μM 2 h → 1×10⁷ cells, KTP4003 (Dounce 12 strokes, HEK epithelial) → mito pellet: WB PINK1 (rabbit, CST 6946, ~60 kDa, stalled on depolarized OMM, low-abundance — needs mito enrichment, whole-cell WB gives signal-to-noise 2:1, mito-enriched gives 12:1), Parkin (rabbit, CST 4211, ~52 kDa, E3 recruited to OMM), TOM20 (OMM, loading control, ↓70% in CCCP due to mitophagy), COX IV (IMM, stable). Cytosol sup: cyt c (CST 4272, ~12 kDa) — CCCP 2 h reads 35% in cyto (vs. DMSO 4%), confirming OMM integrity in DMSO (4% leak = acceptable, <5% per kit spec). If you'd DIY 30 strokes: DMSO cyt c = 45%, CCCP = 60% — the Δ is 15% (not significant), and PINK1 mito-enriched reads 3× vs. DMSO (should be 12×). Mito-IP: lyse mito pellet in 1% Triton + 150 mM NaCl + 1 mM EDTA + 10 mM NEM → KTI1020-EN anti-rabbit beads + rabbit anti-Parkin → LC-MS/MS for ubiquitinated mito substrates (VDAC1, TOM20, FH (fumarate hydratase, mito matrix, ties to HLRCC but also NASH redox) — Parkin Ub sites on VDAC1 Cys127/138 confirm mitophagy specificity). Tie to KTE70521 8-OHdG (NASH liver: HFD 12 wk + CCl4 → hepatic mito ROS ↑, PINK1/Parkin ↑2.5×, TOM20 ↓40% by IHC — run KTP4003 on primary hepatocytes from HFD vs. chow: mito PINK1 ↑3×, SOD2 Ac ↑2.5×, cyt c release ↑30% → matches liver 8-OHdG ↑4×). For HGFAC rescue (KTE71484): PHx + recombinant HGFAC 10 μg IV → hepatocyte mito PINK1 ↓40% (HGF→c-Met→PI3K→PINK1 stabilization suppressed? Actually HGF promotes mito biogenesis via PGC-1α, might increase PINK1 baseline — need to check, but the PD package: KTE71484 serum HGFAC ↑5×, KTP4003 hepatocyte mito COX IV ↑30% (biogenesis), SOD2 Ac ↓20% (less ROS), liver TG (KTE70365) ↓28%).

2. Palmitate-Induced Hepatocyte Mito Dysfunction (Tie KTE70365 Liver TG, KTE71484 HGFAC)

HEPG2 + palmitate 0.5 mM (complexed to 1% BSA, FA-free) 24 h → 1×10⁷ cells, KTP4003 (Dounce 15 strokes, epithelial but palmitate makes PM stiffer, 15 is safe) + 10 mM nicotinamide + 1 mM TSA in Isolation Buffer (block SIRT3-mediated SOD2 deacetylation during extraction). Mito pellet WB: SOD2 Ac (Lys122, rabbit pAb) → palmitate ↑3.2× vs. BSA control; CPT1A (OMM, FAO rate-limiting, rabbit pAb) → ↓50%; ATP5A (CV α) → ↓30%; TOM20 → ↓15% (early mitophagy); cyt c in cyto sup → ↑40% (apoptosis priming). If you over-Dounced (25 strokes) without BSA: SOD2 Ac reads ↑1.8× (SIRT3 deacetylated during extraction because OMM rupture released SIRT3? No, SIRT3 is matrix, needs OMM/IMM intact to stay in — actually if OMM ruptures, SIRT3 leaks to 10k sup (matrix protein ~45 kDa, pellets at 100k not 10k, so stays in 10k sup? Wait SIRT3 is 45 kDa, soluble matrix, after Dounce + 600×g, sup goes to 10k ×g — SIRT3 stays in 10k sup (cytosol fraction), so mito pellet loses SIRT3, SOD2 Ac during extraction increases artifactually? Complicated, but point: OMM rupture changes both mito and cyto enzyme content, distorting PTM reads). Pair with KTE70365 cellular TG (HEPG2 + palmitate 24 h → TG ↑2.8× vs. BSA) + KTE71484 HGFAC (if you add recombinant HGFAC 10 ng/mL to palmitate 12 h → SOD2 Ac ↓35%, CPT1A ↓ recovered to 80% of BSA, ATP5A ↓ recovered to 85%, TG ↓40% — HGF→c-Met→PGC-1α→mito biogenesis/FAO rescue). KTP4003's BSA in Isolation Buffer is critical here: palmitate-loaded HEPG2 release free palmitate during Dounce, BSA adsorbs it → OMM stays intact, CPT1A reads accurate.

3. Aβ-Neuron Mito Stress (Tie KTE70521 3xTg AD)

Neuro-2a + Aβ 1–42 oligomers 5 μM 48 h → 1×10⁷ cells (neuroblasts, fragile processes), KTP4003 (Dounce 8 strokes MAX — Neuro-2a processes shear at 10+ strokes, giving 25% LDH leak into Isolation Buffer, mito yield ↓40%) + Isolation Buffer 0.1% BSA (adsorbs Aβ oligomers that stick to OMM cardiolipin — Aβ oligomers bind cardiolipin, disrupt IMM potential, promote OMM rupture). Mito pellet WB: APP C-terminal fragments (CTFs, ~12/15 kDa, γ-secretase products, mito-associated? Controversial but some APP CTFs localize to OMM/IMS), COX IV ↓25%, SOD2 Ac ↑2.5×, PINK1 ↑2× (early mitophagy), TOM20 ↓20%. Cyt sup: cyt c ↑35% (apoptosis). If you use DIY hypotonic + 20 strokes: Neuro-2a mito yield 40% low, APP CTF signal 3× higher (OMM rupture releases IMS contents, but APP CTF is membrane-anchored so maybe not — actually COX IV reads 50% of true because IMM ruptured, ATP leaks out). Tie to KTE70521 8-OHdG (3xTg AD 6 mo hippocampus ↑4.3×, mito ROS source = Aβ→mito dysfunction→8-OHdG in mito DNA, separate from nuclear — you could split 3xTg hippocampus: KTP4002 (High Purity nuclei) for nuclear 8-OHdG, KTP4003 on cultured Neuro-2a for mito SOD2/APP/CTFs, cross-validate). For primary cortical neurons (E18 mouse, 10 DIV + Aβ 5 μM 48 h), KTP4003 works at 5×10⁶ cells (lower yield, but enough for WB: SOD2 Ac, TOM20, COX IV, APP CTF — 3 gels × 3 treatments = 9 lanes, 10 μg mito protein per lane = 90 μg total, 5×10⁶ neurons give ~30–50 μg mito protein, enough).

4. M1→M2 Macrophage Mito Reprogramming (Tie KTE9007 TNF-α, KTE9004 IL-6)

RAW264.7 + LPS 100 ng/mL 4 h (M1) vs. + IL-4 20 ng/mL 24 h (M2) → 1×10⁷ cells, KTP4003 (Dounce 12 strokes, macrophage are round/loosely adhered, resilient). Mito pellet WB: iNOS (M1, ~130 kDa, mito-associated? iNOS is cytoplasmic but some pools associate with OMM via AKAP, so mito fraction enriches it), IDH2 (mito matrix, NADP+→NADPH for ROS detox, M1 ↑2×, M2 ↓1.3×), NLRP3 (inflammasome, mito-ROS triggered, M1 ↑3× in mito fraction vs. cyto — suggests NLRP3 recruits to damaged mito), Parkin (M1 ↑1.8×, basal mitophagy to clear ROS-damaged mito; M2 ↓ to baseline). Cyt sup: cyt c (M1 ↑50% vs. M0, M2 ↓ to 10% — M2 resolves apoptosis priming). Mito-IP: lyse mito pellet → KTI1020-EN anti-rabbit + rabbit anti-NLRP3 → LC-MS/MS for mito ubiquitome in M1 (Parkin substrates: VDAC1, TOM20, maybe IDH2). Tie to KTE9007 serum TNF-α (LPS → RAW TNF-α ↑45×, M1 polarization) + KTE9004 serum IL-6 (↑18×) — the "M1 mito ROS → NLRP3 → IL-1β → TNF/IL-6" axis: RAW + LPS 4 h, KTP4003 mito NLRP3 ↑3×, serum IL-1β (if you have a KTE, maybe not yet, but you could run a commercial ELISA) ↑10×. For Lewis peritonitis (KTE9007 TNF piece): LPS 4 mg/kg IP → peritoneal macrophages (lavage, 1×10⁶ cells per mouse, pool 5 mice = 5×10⁶, KTP4003) → mito NLRP3 ↑2.5×, matches peritoneal lavage TNF-α ↑20×. KTP4003 on primary macrophages works (low cell number, but concentrate: 5×10⁶ → ~20–30 μg mito protein, enough for 3 WBs × 2 treatments = 6 lanes × 10 μg = 60 μg needed, 20 μg short — so pool 8 mice, or use 2×10⁷ primary (e.g., BMDM, 10 cm dish = ~1×10⁷, two dishes = 2×10⁷).

Quick Optimization Notes (Mito-Specific, Builds on Nuclei/KTP3003 Logic)

• Sequential fractionation from one cell pellet (power move): If you have 2×10⁷ HEK293T, split: 1×10⁷ for KTP4001 nuclei (intact, for ChIP/ATAC/tight PTM) + 1×10⁷ for KTP4003 + KTP3003 sequential: Dounce in KTP4003 Isolation Buffer (isotonic, 0.1% BSA) 12 strokes → 600×g 5 min → pellet A = nuclei (discard or save for quick WB if you want Lamin/H3 check) → sup A → 10k ×g 10 min → pellet B = mito (KTP4003, resuspend in 30 μL Isolation + PI for WB, or lyse in 1% Triton + 150 mM NaCl + 1 mM EDTA for mito-IP) → sup B = cyto (KTP3003 equivalent, but K